Racial inequities uncovered in hospital admissions for heart failure

October 29, 2019

DALLAS, Oct. 29, 2019 - People who are Black or of Latin American descent with heart failure are less likely to be admitted to specialized cardiology units, a disparity that may help explain long-known racial differences in heart failure outcomes, according to new research published in the American Heart Association's journal Circulation: Heart Failure.

The retrospective, single-center study is one of the first to demonstrate that racial inequities in the type of care received, either specialized cardiac care or general care, for patients admitted to the hospital with heart failure may drive subsequent racial inequities in heart failure outcomes. Researchers reviewed hospital admissions and discharges for 10 years to yield nearly 2,000 patients treated for heart failure at Brigham and Women's Hospital in Boston.

After adjusting for a variety of demographic and clinical factors, the analysis found:"These outcomes are both unjust and avoidable, and in no way unique to a single institution," said co-lead study author Lauren Eberly, M.D., M.P.H., who was a resident physician at Brigham and Women's Hospital when the study was conducted. "We hope that our findings will encourage other institutions to investigate how racial bias influences care decisions at their center as Brigham and Women's Hospital supported our inquiry. We recommend that care delivery be designed to prioritize the care of our most marginalized patients. Only then can we start to eliminate inequity." Eberly is now a cardiovascular medicine fellow at the University of Pennsylvania.

Racial inequities and higher readmission rates among minority populations have been documented in previous studies, however, this study's findings suggest that admission practices may provide a partial explanation behind these well-known racial disparities in heart failure outcomes. The researchers emphasize that the observed disparities in outcomes likely stem from structural and systemic differences in care rather than biological differences in disease progression for people of different ancestries.

"Future research on health inequities should seriously consider looking beyond biological differences between races to critical issues of inequities in access to care as key drivers of racial disparities," said a senior study author Michelle Morse, M.D., M.P.H., a hospitalist at Brigham and Women's Hospital and assistant professor of medicine at Harvard Medical School.

The factors behind the difference in admission patterns are likely multifactorial, the researchers said, but reflect inequities in outpatient access to outpatient cardiology care: black and Latinx patients were not under the care of a cardiologist as an outpatient at the time of hospitalization--the strongest predictor of admission to a cardiology unit, according to the study. Levels of perceived discrimination and mistrust in the healthcare system may also lead to differential self-advocacy for admission to a specialized service by patients from different backgrounds. While structural drivers are likely the major drivers, the authors feel that implicit bias is ubiquitous and probably contributes as well.

The study was not designed to uncover the reasons behind the higher readmission rates among those treated in the general medicine unit. However, the difference in outcomes may be driven by the greater expertise, improved overall care and specialized support services with focus on cardiac illness that are available in cardiology units. The researchers noted that premature discharge, inadequate transitions of care from the hospital to home and lower rates of cardiology follow-up for those admitted to general medicine may also worsen patient outcomes.

Decision tools and guidelines for admissions staff and racial equity training for clinicians could help close the gap in access to specialized cardiac care and to improve outcomes. Increased staff education could also help to standardize heart failure care between cardiology and general medicine units. Additional tools may include strategies to ensure that all patients are followed by a cardiologist after leaving the hospital, the researchers said.

"Research has shown that structural inequities are pervasive throughout health care systems. But identifying inequities is the first step in a process. With significant institutional support and leadership commitment, we have begun the important work of addressing these inequities. We hope other institutions and clinicians will be equally committed to addressing inequities in their own contexts, systems and care settings," said senior study author Eldrin Lewis, M.D., Ph.D., a cardiovascular specialist at Brigham and Women's Hospital and associate professor of medicine at Harvard Medical School. "Equity must be central in everything we do as physicians."
Other authors are co-lead author Aaron Richterman, M.D.; Anne Beckkett, M.D.; Bram Wispelwey, M.D., Ph.D.; Regan Marsh, M.D., Ph.D.; Emily C. Cleveland Manchanda, M.D., M.P.H.; Cindy Chang, M.D., Ph.D.; Robert Glynn, Sc.D., Ph.D.; Katherine Brooks, M.D.; Robert Boxer, M.D., Ph.D.; Rose Kakoza, M.D.; Jennifer Goldsmith, M.Ed.; and Joseph Loscalzo, M.D., Ph.D. No external funding is reported.

Additional Resources:

Available multimedia is on right column of release link - https://newsroom.heart.org/news/racial-inequities-uncovered-in-hospital-admissions-for-heart-failure?preview=4bd20f55ecb98d54c46871260b74e76f

After Oct. 29, 2019, view the manuscript online.

Living with Heart Failure and Managing Advanced HF

American Heart Association: Get With The Guidelines® - Heart Failure

Follow AHA/ASA news on Twitter @HeartNews

Statements and conclusions of study authors published in American Heart Association scientific journals are solely those of the study authors and do not necessarily reflect the Association's policy or position. The Association makes no representation or guarantee as to their accuracy or reliability. The Association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific Association programs and events. The Association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and device corporations and health insurance providers are available at https://www.heart.org/en/about-us/aha-financial-information.

About the American Heart Association

The American Heart Association is a relentless force for a world of longer, healthier lives. We are dedicated to ensuring equitable health in all communities. Through collaboration with numerous organizations, and powered by millions of volunteers, we fund innovative research, advocate for the public's health and share lifesaving resources. The Dallas-based organization has been a leading source of health information for nearly a century. Connect with us on heart.org, Facebook, Twitter or by calling 1-800-AHA-USA1.

American Heart Association

Related Heart Failure Articles from Brightsurf:

Top Science Tip Sheet on heart failure, heart muscle cells, heart attack and atrial fibrillation results
Newly discovered pathway may have potential for treating heart failure - New research model helps predict heart muscle cells' impact on heart function after injury - New mass spectrometry approach generates libraries of glycans in human heart tissue - Understanding heart damage after heart attack and treatment may provide clues for prevention - Understanding atrial fibrillation's effects on heart cells may help find treatments - New research may lead to therapy for heart failure caused by ICI cancer medication

Machining the heart: New predictor for helping to beat chronic heart failure
Researchers from Kanazawa University have used machine learning to predict which classes of chronic heart failure patients are most likely to experience heart failure death, and which are most likely to develop an arrhythmic death or sudden cardiac death.

Heart attacks, heart failure, stroke: COVID-19's dangerous cardiovascular complications
A new guide from emergency medicine doctors details the potentially deadly cardiovascular complications COVID-19 can cause.

Autoimmunity-associated heart dilation tied to heart-failure risk in type 1 diabetes
In people with type 1 diabetes without known cardiovascular disease, the presence of autoantibodies against heart muscle proteins was associated with cardiac magnetic resonance (CMR) imaging evidence of increased volume of the left ventricle (the heart's main pumping chamber), increased muscle mass, and reduced pumping function (ejection fraction), features that are associated with higher risk of failure in the general population

Transcendental Meditation prevents abnormal enlargement of the heart, reduces chronic heart failure
A randomized controlled study recently published in the Hypertension issue of Ethnicity & Disease found the Transcendental Meditation (TM) technique helps prevent abnormal enlargement of the heart compared to health education (HE) controls.

Beta blocker use identified as hospitalization risk factor in 'stiff heart' heart failure
A new study links the use of beta-blockers to heart failure hospitalizations among those with the common 'stiff heart' heart failure subtype.

Type 2 diabetes may affect heart structure and increase complications and death among heart failure patients of Asian ethnicity
The combination of heart failure and Type 2 diabetes can lead to structural changes in the heart, poorer quality of life and increased risk of death, according to a multi-country study in Asia.

Preventive drug therapy may increase right-sided heart failure risk in patients who receive heart devices
Patients treated preemptively with drugs to reduce the risk of right-sided heart failure after heart device implantation may experience the opposite effect and develop heart failure and post-operative bleeding more often than patients not receiving the drugs.

How the enzyme lipoxygenase drives heart failure after heart attacks
Heart failure after a heart attack is a global epidemic leading to heart failure pathology.

Novel heart pump shows superior outcomes in advanced heart failure
Severely ill patients with advanced heart failure who received a novel heart pump -- the HeartMate 3 left ventricular assist device (LVAD) -- suffered significantly fewer strokes, pump-related blood clots and bleeding episodes after two years, compared with similar patients who received an older, more established pump, according to research presented at the American College of Cardiology's 68th Annual Scientific Session.

Read More: Heart Failure News and Heart Failure Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.